Insight #1 – A COVID-19 vaccine is highly bullish for cyclical stocks across Asia Pfizer’s announcement about its COVID-19 vaccine having a 95% efficacy is bullish for cyclical stocks across Asia. Energy, materials, banks, property, insurance, retail, machinery, auto sectors will all benefit. A risk-on environment might also attract portfolio flows back to riskier emerging markets such as Indonesia and the Philippines. The timeline for mass distribution is unclear. Up to three vaccines could potentially be available by January. But it would take many months - perhaps even a year - for the logistics industry to build out the capacity to
Asia links 19 Nov 2020: Vaccines, Chinese EV…
Insight #1 – A COVID-19 vaccine is highly bullish for cyclical stocks across Asia Pfizer’s announcement about its COVID-19 vaccine having a 95% efficacy is bullish for cyclical stocks across Asia. Energy, materials, banks, property, insurance, retail, machinery, auto sectors will all benefit. A risk-on environment might also attract portfolio flows back to riskier emerging markets such as Indonesia and the Philippines. The timeline for mass distribution is unclear. Up to three vaccines could potentially be available by January. But it would take many months - perhaps even a year - for the logistics industry to build out the capacity to
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.